2021’s Speaker Line-Up

Arndt Schottelius

CSO

Affimed

Joachim Koch

Head of Translational Research & Innovation

Affimed

Sonny Hsiao

Founder & CEO

Acepodia

Sylvia Lee

Senior Research Scientist

Acepodia

Eugene Helsel

VP, Regulatory Affairs & Quality

Artiva Biotherapeutics

Jason Litten

CMO

Artiva Biotherapeutics

Marco Purbhoo

Director Translational Research

AgenTus

Sara Padrell Sánchez

Business Development Director, Europe

Akron Biotech

Gabriella Perell

Product Manager, Cell & Gene Therapy

Bio-Techne

Joseph Lomakin

Senior Manager, Process Development, Cell & Gene Therapy

Bio-Techne

Matthew Klinker

Biologist, Cell Therapy Branch, Division of Cellular and Gene Therapies

CBER

Robert Hariri

CEO

Celularity

Elie Haddad

Head, Research Axis, Immune Disorders & Cancers

CHU Sainte-Justine

Jennifer Dashnau

Head of Analytical Development & Quality Control

Century Therapeutics

Mark Wallet

VP, Head of Immunology

Century Therapeutics

Xiaokui Zhang

CSO

Celularity

Daniel Teper

CEO

Cytovia Therapeutics

Marlin Frechette

Senior Director, Quality Systems, Regulatory Affairs & Compliance

FUJIFILM Irvine Scientific

Rizwan Romee

Associate Professor, Harvard Medical School

Dana Farber Cancer Institute

Wei Li

CSO

Cytovia Therapeutics

Amy Sharma

Project Lead Scientist, Development

Genentech Inc.

John Lu

President & CEO

HebeCell

Mark Lowdell

CSO

Inmune Bio

Tracey Lodie

CSO

Gamida Cell

Björn Önfelt

Associate Professor

Karolinska Institute

Hans-Gustaf Ljunggren

Professor

Karolinska Institute

Kurt Gunter

CMO

Kuur Therapeutics

Robert Igarashi

VP, Discovery & Pre-Clinical Development

Kiadis Pharma

Dr. Will Singleterry

Commercial Director, Immuno-Oncology

LUMICKS

Emily Levy

Postdoctoral Research Fellow, Laboratory of Transplantation Immunotherapy, NHLBI

NIH

Martha Luevano Salinas

Global Product Manager & Group Leader Immunology Engineered Cells

Miltenyi Biotec

Richard Childs

Rear Admiral, Commissioned Corps Unites States Public Health Service, NHLBI

NIH

Chris Nowers

CEO

ONK Therapeutics

James Trager

CSO

Nkarta Therapeutics

Michael O’Dwyer

CSO

ONK Therapeutics

Stephen Chen

CTO

NK Max America

Lan Cao

Head, Platform & Product Development, Cell Therapy

Takeda

Nick Huntington

CSO

oNKo-Innate Pty Ltd

Sandro Matosevic

Assistant Professor

Purdue University

Stacey Cranert

PhD Associate Director, Immuno-Oncology

Poseida Therapeutics

Anahid Jewett

Professor

University of California Los Angeles

Dan Kaufman

Professor

University of California

Nina Shah

Associate Professor

UCSF

Silke Paust

Associate Professor

Scripps Institute

Christian Capitini

Associate Professor, Pediatrics

University of Wisconsin

Frank Cichocki

Assistant Professor of Medicine

University of Minnesota

Jeffrey Miller

Professor

University of Minnesota

Veronika Bachanova

Professor of Medicine

University of Minnesota Medical School

Evren Alici

CEO

Vycellix

Stewart Abott

CSO

Adicet Bio

Subramaniam Malarkannan

Senior Investigator, Gardetto Chair for Molecular Immunology & Immunotherapy

Versiti

Todd Fehniger

Professor of Medicine

Washington University School of Medicine in St Louis

Basile Siewe

Director, Business Development

The Jackson Laboratory

Josh Ludwig

US Commercial Director

ScaleReady

Rafael Bravo

Collection Network Liaison

Be The Match BioTherapies

Stacey Willard

Director of Product Growth

IsoPlexis